Advancing toward more meaningful use of PRO data by making it systematic, transparent, and built into trial design.
Jens Lehmann, PhD
Advertisement
With the Health Outcomes Research Unit, University Hospital of Psychiatry II, Medical University of Innsbruck, Austria
Articles by Jens Lehmann, PhD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
FDA Approves UCB’s Kygevi for TK2 Deficiency Based on Multi-Study Clinical Program Demonstrating Significant Survival and Motor Gains
2
Inside the Recruitment Bottlenecks Driving Trial Delays
3
Takeda’s Phase III TIDES Trial Confirms Long-Term Efficacy and Safety of Qdenga Dengue Vaccine
4
ACT Brief: Tech-Driven Data Strategies and Long-Term Vaccine Success
5
.png "BioPharm International")
.png "Pharmaceutical Commerce"){kind=logo}
.png "Turbo Machinery Magazine")
.png){kind=spacer}
